OxyPrime

OxyPrime is a clinical-stage biotechnology company focused on developing perfluorocarbon-based oxygen carriers (PFCOCs) for acute medical applications. The company's primary technology involves stable emulsions of perfluorocarbons that possess a high capacity for dissolving respiratory gases, allowing for enhanced oxygen delivery to tissues. OxyPrime is targeting critical care indications where oxygen supply is compromised, including decompression sickness, traumatic brain injury, and hemorrhagic shock. By providing a synthetic, shelf-stable alternative to traditional blood products, the company aims to improve outcomes in emergency and military medicine.